Endoscopic esophageal stenting for advanced esophageal cancer in Lubaga Hospital, Kampala, Uganda
-
Published:2022-11-01
Issue:1
Volume:15
Page:
-
ISSN:1756-0500
-
Container-title:BMC Research Notes
-
language:en
-
Short-container-title:BMC Res Notes
Author:
Okello Michael,Darshit Dave,Nabwire Esther Patience,Tinka Anna Ainembabazi,Bakeera-Kitaka Sabrina,Ocama Ponsiano
Abstract
Abstract
Objective
Esophageal cancer is a common malignancy globally. Most patients in sub-Saharan Africa present at advanced stage not amenable to curative therapy. Stenting provides palliation for these patients. In Uganda, many endoscopy units can perform diagnostic endoscopy but only a handful routinely perform endoscopic interventions like stenting. We describe esophageal cancer patients who underwent esophageal stenting intending to highlight its importance in a resource-limited setting.
Endoscopy reports were reviewed for patients who underwent evaluation for esophageal cancer at Lubaga Hospital from December 2014 to March 2022.
Results
315 records of patients with esophageal cancer were reviewed. Male to female ratio was 2:1. 188(60%) patients were 60 years and above. 268 (85%) esophageal lesions were described as fungating, friable or polypoid. 249 (79%) tumors were in mid or distal esophagus. 66% esophageal lesions caused severe luminal obstruction not traversable by the scope. 164 (52%) patients did not opt for stenting due to personal and other reasons. Stenting wasn’t successful in 7 out of the 148 patients who underwent either primary or tandem stenting. Despite 207 (66%) of patients with advanced esophageal cancer presenting with endoscopically non-traversable tumors, endoscopic stenting was still possible with a technical success rate of 95.3%.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Galukande M, Luwaga A, Jombwe J, et al. Oesophageal cancer management guidelines for Uganda. East Cent Afr J Surg. 2008;13(2):132–41.
2. Ocama P, Kagimu M, Odida M, et al. Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda. Afr Health Sci. 2008;8(2):80.
3. Vermeulen BD, Siersema PD. Esophageal stenting in clinical practice: an overview. Curr Treat Options Gastroenterol. 2018;16(2):260–73.
4. Sami SS, Haboubi HN, Ang Y, et al. UK guidelines on oesophageal dilatation in clinical practice. Gut. 2018;67(6):1000–23.
5. Ebigbo A, Palm C, Probst A, et al. A technical review of artificial intelligence as applied to gastrointestinal endoscopy: clarifying the terminology. Endosc Int Open. 2019;7(12):E1616–23.